Article Information
History
- June 30, 2022.
Article Versions
- Version 1 (June 27, 2022 - 09:48).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sara K. Nsibirwa1,2,*,§,
- Jim Aizire1,3,*,
- David L. Thomas1,3,
- Ponsiano Ocama1,4 and
- Gregory D. Kirk1,3,§
- 1HIV and HCC in Uganda (H2U) Consortium, Kampala, Uganda
- 2Infectious Diseases Institute (IDI), Kampala, Uganda
- 3Johns Hopkins University, Baltimore, MD, USA
- 4Makerere University College of Health Sciences, Kampala, Uganda
- 5Uganda Cancer Institute, Kampala, Uganda
- ↵§Address correspondence and reprint requests to: Gregory D. Kirk, MD, MPH, PhD, Professor of Epidemiology, Oncology and Medicine, Johns Hopkins University, Telephone: +1(410)-502-2038, e-mail: gdk{at}jhu.edu And Sara Nsibirwa, MD, MPH, Infectious Disease Institute, Makerere University, Telephone: +256787639100, email: snsibirwa{at}idi.co.ug
↵* These authors have contributed equally to the work
Posted June 30, 2022.
Rapid progression to death after hepatocellular carcinoma diagnosis particularly among persons with advanced HIV disease in Kampala, Uganda
